Gerwin, Nicole http://orcid.org/0000-0002-4724-1595
Scotti, Celeste
Halleux, Christine
Fornaro, Mara
Elliott, Jimmy
Zhang, Yunyu
Johnson, Kristen
Shi, Jian
Walter, Sandra
Li, Yufei
Jacobi, Carsten
Laplanche, Nelly
Belaud, Magali
Paul, Jochen
Glowacki, Gustavo
Peters, Thomas
Wharton, Keith A. Jr
Vostiar, Igor
Polus, Florine
Kramer, Ina
Guth, Sabine
Seroutou, Abdelkader
Choudhury, Subhajit
Laurent, Didier http://orcid.org/0000-0002-4507-1334
Gimbel, Joseph
Goldhahn, Jörg http://orcid.org/0000-0003-0012-0494
Schieker, Matthias
Brachat, Sophie
Roubenoff, Ronenn http://orcid.org/0000-0002-3959-3179
Kneissel, Michaela
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 6 December 2021
Accepted: 28 September 2022
First Online: 1 December 2022
Competing interests
: N.G., C.S., C.H., M.F., J.E., Y.Z., J.S., S.W., Y.L., C.J., N.L., M.B., G.G., T.P., I.V., I.K., S.G., A.S., D.L., M.S., S.B., R.R. and M.K. are employees and shareholders of Novartis. F.P. is an employee of Novartis. S.C. is a current employee of IQVIA and was an employee of Novartis Healthcare. K.J. is a current employee of Calibr and was an employee of the Novartis Institutes for BioMedical Research. K.A.W. is a current employee and equity owner in Ultivue and a former employee and stockholder in Leica Biosystems/Danaher and the Novartis Institutes for BioMedical Research. J. Goldhahn was an employee of the Novartis Institutes for BioMedical Research and has no other competing interests. J.P. and J. Gimbel declare no competing interests.